Artiva Biotherapeutics, Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
ARTV$4.22+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit number · Incorporated by Reference · FiledHerewith | |||||
|---|---|---|---|---|---|
| Description of document · Form · Date · Number | |||||
| 3.1 | Amended and Restated Certificate of Incorporation. | 8-K | 7/22/2024 | 3.1 | |
| 3.2 | Amended and Restated Bylaws. | S-1 | 6/28/2024 | 3.4 | |
| 4.1 | Form of Common Stock Certificate of the Registrant. | S-1/A | 7/15/2024 | 4.1 | |
| 4.2 | Amended and Restated Investors’ Rights Agreement, dated February 22, 2021, by and among the Registrant and certain of its stockholders. | S-1 | 6/28/2024 | 4.2 | |
| 4.3 | Form of Pre-Funded Warrant issued on May 11, 2026. | X | |||
| 10.1+ | Separation Agreement, dated May 18, 2026, by and between the Registrant and Thad Huston. | X | |||
| 10.2+ | Employment Offer Letter, dated May 18, 2026, by and between the Registrant and Diego Miralles. | X | |||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 101.INS | Inline XBRL Instance Document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With embedded Linkbase Documents Document | X | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X | |||
- Indicates management contract or compensatory plan
- This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.